Why People Consider Swapping Between These Treatments
Understanding Why You Might Swap From Mounjaro To Wegovy
The decision to swap from Mounjaro to Wegovy typically involves several clinical considerations that your prescriber can help evaluate. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors as a dual agonist. Some patients find one mechanism suits their individual response better than the other, though both are designed to work alongside a reduced-calorie diet and increased physical activity. Your prescriber may suggest switching based on your tolerance, response patterns, or practical considerations such as storage requirements during travel.
At EverydayMeds, we understand that finding the right weight management treatment can involve some adjustment. Both Wegovy and Mounjaro are available through our GPhC-registered pharmacy (#9012878), meaning you won't need to change providers when considering a swap from Mounjaro to Wegovy. This continuity ensures your medical history and treatment progress remain with familiar healthcare professionals who understand your journey. Our clinical team can coordinate the transition timing to ensure appropriate washout periods and dose escalation schedules are followed safely.
Wegovy vs Mounjaro Pricing: Complete Cost Comparison When You Swap
When planning to swap from Mounjaro to Wegovy, understanding the pricing structure helps with treatment planning and budgeting. Wegovy pricing at EverydayMeds starts with 0.25mg at £79.99, progresses to 0.5mg at £94.99, then 1mg at £99.99, 1.7mg at £139.99, and maintenance 2.4mg at £209.99. New customers benefit from code FIRST40 whilst returning customers use DOSE25, both applied at checkout to reach these final prices. Our bundle options provide convenience for multi-month supply planning, such as the Intro Trio (0.25mg, 0.5mg, 1mg) at £299.99 for those beginning the full dose escalation schedule.
The cost consideration when you swap from Mounjaro to Wegovy involves understanding that Wegovy requires a specific 20-week dose escalation protocol starting from 0.25mg. This structured approach means your initial costs will be lower than the maintenance phase, allowing you to assess tolerance before committing to higher-dose pricing. Our Getting Started bundles like the Intro Duo (0.25mg & 0.5mg) at £169.99 provide the first 8 weeks of treatment in one order, whilst our Consistency bundles offer multiple pens of the same strength once you reach your optimal maintenance dose.
Clinical Evidence Behind Swapping From Mounjaro To Wegovy Decisions
The STEP clinical trial programme provides the evidence base supporting Wegovy for weight management in adults with BMI ≥30 or ≥27 with comorbidities. In clinical trials, patients taking Wegovy alongside diet and exercise achieved an average weight reduction of approximately 15% at 68 weeks in STEP 1, with the SELECT cardiovascular outcomes trial demonstrating a 20% reduction in major cardiovascular events. However, it's important to understand that individual responses vary significantly, and your prescriber will consider your specific medical history when evaluating a potential swap from Mounjaro to Wegovy.
When comparing clinical evidence, both Wegovy and Mounjaro have demonstrated efficacy in their respective trial programmes, though direct head-to-head comparisons aren't available due to different trial designs and populations. The decision to swap from Mounjaro to Wegovy should be based on individual factors such as tolerance, response, and clinical objectives rather than attempting to compare trial percentages between different study protocols.
How Wegovy Works When You Swap From Mounjaro Treatment
Wegovy contains semaglutide, which functions as a GLP-1 receptor agonist, mimicking the action of a naturally occurring hormone that regulates appetite and food intake. After injection, semaglutide binds to GLP-1 receptors in the brain's appetite centres, promoting feelings of fullness and reducing hunger signals between meals. This mechanism may help reduce overall caloric intake by making smaller portions feel more satisfying and potentially diminishing food cravings throughout the day. Unlike Mounjaro's dual receptor approach, Wegovy focuses specifically on the GLP-1 pathway, which some patients find suits their physiology better. The once-weekly injection schedule provides sustained medication levels, maintaining appetite regulation effects throughout the seven-day dosing interval while working alongside your dietary and exercise efforts.
Complete Process For Swapping From Mounjaro To Wegovy At EverydayMeds
Beginning your swap from Mounjaro to Wegovy starts with our comprehensive 3-minute online clinical assessment, which captures your current treatment history, response to Mounjaro, and reasons for considering the switch. Our prescribers review your submission within 3 working days (or 24 hours with express service), evaluating whether Wegovy represents an appropriate alternative and determining optimal timing for the transition. Once approved, your Wegovy prescription is prepared and dispatched via next-day delivery using our temperature-controlled cold-chain system to ensure medication integrity. The assessment specifically addresses switching protocols, including any recommended washout period between treatments and confirms your starting dose based on your previous experience with GLP-1 pathway medications. Our pharmacy team coordinates delivery timing to ensure seamless continuation of your weight management programme without unnecessary treatment gaps.
Storage and Practical Advantages When You Swap From Mounjaro To Wegovy
One practical advantage that influences some patients to swap from Mounjaro to Wegovy involves storage flexibility, particularly for those who travel frequently or have variable schedules. Wegovy pens can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. The FlexTouch pen system delivers doses through a simple click-mechanism, with clear dose counters and safety features that many patients find intuitive after transitioning from other injection systems. Wegovy's dose escalation follows a structured 20-week protocol (0.25mg, 0.5mg, 1mg, 1.7mg, then 2.4mg maintenance), which some prescribers prefer for its gradual tolerance-building approach. Like all prescription-only medicines, Wegovy requires proper storage in the refrigerator at 2-8°C before first use, and our delivery system ensures pens arrive in optimal condition regardless of external temperatures.
Switching Considerations: Wegovy's GLP-1 Focus vs Mounjaro's Dual Mechanism
The fundamental difference between these medications lies in their receptor targeting: whilst Mounjaro activates both GIP and GLP-1 receptors, Wegovy focuses exclusively on GLP-1 pathways. Some patients who swap from Mounjaro to Wegovy report preferring the more targeted approach, particularly if they experienced specific side effects with dual receptor activation. The single-pathway mechanism may offer more predictable responses for certain individuals, though both treatments require the same commitment to dietary modifications and increased physical activity for optimal results.
Your decision to swap from Mounjaro to Wegovy might also consider injection frequency preferences, storage requirements, and dose escalation schedules that better fit your lifestyle. Both medications are prescription-only medicines requiring ongoing clinical supervision, but the specific monitoring protocols and adjustment options may vary between treatments. At EverydayMeds, our prescribers can evaluate these nuanced differences to support your individual treatment optimization journey.
Complete Your Swap From Mounjaro To Wegovy With Expert Support
Ready to explore whether swapping from Mounjaro to Wegovy suits your weight management goals? Our clinical assessment captures your current treatment experience and evaluates Wegovy's suitability for your individual circumstances. New customers benefit from code FIRST40, whilst returning patients use DOSE25, both applied at checkout for our published pricing. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment, with prescriber review and next-day delivery available once approved. Our GPhC-registered pharmacy (#9012878) ensures you receive genuine Novo Nordisk Wegovy with full clinical support throughout your treatment journey. Both Wegovy and Mounjaro remain available through our service, providing flexibility as your treatment needs evolve with expert prescriber guidance.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
